J 2015

Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies

LABBÉ, Catherine, Kotaro OGAKI, Oswaldo LORENZO-BETANCOR, Alexandra I. SOTO-ORTOLAZA, Ronald L. WALTON et. al.

Basic information

Original name

Role for the microtubule-associated protein tau variant p.A152T in risk of alpha-synucleinopathies

Authors

LABBÉ, Catherine (840 United States of America), Kotaro OGAKI (840 United States of America), Oswaldo LORENZO-BETANCOR (840 United States of America), Alexandra I. SOTO-ORTOLAZA (840 United States of America), Ronald L. WALTON (840 United States of America), Sruti RAYAPROLU (840 United States of America), Shinsuke FUJIOKA (840 United States of America), Melissa E. MURRAY (840 United States of America), Michael G. HECKMAN (840 United States of America), Andreas PUSCHMANN (752 Sweden), Allan MCCARTHY (372 Ireland), Timothy LYNCH (372 Ireland), Joanna SIUDA (616 Poland), Grzegorz OPALA (616 Poland), Monika RUDZINSKA (616 Poland), Anna KRYGOWSKA-WAJS (616 Poland), Maria BARCIKOWSKA (616 Poland), Krzysztof CZYZEWSKI (616 Poland), Yanosh SANOTSKY (804 Ukraine), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), Pamela J. MCLEAN (840 United States of America), Rosa RADEMAKERS (840 United States of America), Niluefer ERTEKIN-TANER (840 United States of America), Anhar HASSAN (840 United States of America), J. Eric AHLSKOG (840 United States of America), Bradley F. BOEVE (840 United States of America), Ronald C. PETERSEN (840 United States of America), Demetrius M. MARAGANORE (840 United States of America), Charles H. ADLER (840 United States of America), Tanis J. FERMAN (840 United States of America), Joseph E. PARISI (840 United States of America), Neill R. GRAFF-RADFORD (840 United States of America), Ryan J. UITTI (840 United States of America), Zbigniew K. WSZOLEK (840 United States of America), Dennis W. DICKSON (840 United States of America) and Owen A. ROSS (840 United States of America)

Edition

Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2015, 0028-3878

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 8.166

RIV identification code

RIV/00216224:14740/15:00085057

Organization unit

Central European Institute of Technology

UT WoS

000364338500009

Keywords in English

adult; aged; alpha synucleinopathies; Article; case control study; controlled study; degenerative disease; diffuse Lewy body disease; disease predisposition

Tags

Tags

International impact, Reviewed
Změněno: 4/4/2016 15:00, Mgr. Eva Špillingová

Abstract

V originále

Objective: To assess the importance of MAPT variant p.A152T in the risk of synucleinopathies. Methods: In this case-control study, we screened a large global series of patients and controls, and assessed associations between p.A152T and disease risk. We included 3,229 patients with clinical Parkinson disease (PD), 442 with clinical dementia with Lewy bodies (DLB), 181 with multiple system atrophy (MSA), 832 with pathologically confirmed Lewy body disease (LBD), and 2,456 healthy controls. Results: The minor allele frequencies (MAF) in clinical PD cases (0.28%) and in controls (0.2%) were not found to be significantly different (odds ratio [OR] 1.37, 95% confidence interval [CI] 0.63-2.98, p 0.42). However, a significant association was observed with clinical DLB (MAF 0.68%, OR 5.76, 95% CI 1.62-20.51, p 0.007) and LBD (MAF 0.42%, OR 3.55, 95% CI 1.04-12.17, p 0.04). Additionally, p.A152T was more common in patients with MSA compared to controls (MAF 0.55%, OR 4.68, 95% CI 0.85-25.72, p 0.08) but this was not statistically significant and therefore should be interpreted with caution. Conclusions: Overall, our findings suggest that MAPT p.A152T is a rare low penetrance variant likely associated with DLB that may be influenced by coexisting LBD and AD pathology. Given the rare nature of the variant, further studies with greater sample size are warranted and will help to fully explain the role of p.A152T in the pathogenesis of the synucleinopathies. © 2015 American Academy of Neurology.

Files attached

ZVV_2015_143_1319706_Role_of_the_microtubule.pdf
Request the author's version of the file